114 related articles for article (PubMed ID: 12942100)
1. FK506-associated limbic injury following umbilical cord blood transplantation.
Yoshida Y; Shimada H; Mori T; Yoshihara H; Takeoka M; Takahashi T
Bone Marrow Transplant; 2003 Sep; 32(5):523-5. PubMed ID: 12942100
[TBL] [Abstract][Full Text] [Related]
2. FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation.
Misawa A; Takeuchi Y; Hibi S; Todo S; Imashuku S; Sawada T
Bone Marrow Transplant; 2000 Feb; 25(3):331-4. PubMed ID: 10673708
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation.
Devine SM; Newman NJ; Siegel JL; Joseph GJ; Geis TC; Schneider JA; Geller RB; Wingard JR
Bone Marrow Transplant; 1996 Sep; 18(3):569-72. PubMed ID: 8879619
[TBL] [Abstract][Full Text] [Related]
4. [A case of FK 506-induced leukoencephalopathy].
Okoshi Y; Itoh M; Okimoto Y; Horie H; Takashima S
No To Shinkei; 2002 Jan; 54(1):51-5. PubMed ID: 11868353
[TBL] [Abstract][Full Text] [Related]
5. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
Miyakoshi S; Kami M; Tanimoto T; Yamaguchi T; Narimatsu H; Kusumi E; Matsumura T; Takagi S; Kato D; Kishi Y; Murashige N; Yuji K; Uchida N; Masuoka K; Wake A; Taniguchi S
Transplantation; 2007 Aug; 84(3):316-22. PubMed ID: 17700155
[TBL] [Abstract][Full Text] [Related]
7. Food allergy after cord blood stem cell transplantation with tacrolimus therapy in two patients who developed veno-occlusive disease.
Inoue Y; Ochiai H; Hishiki T; Shimojo N; Yoshida H; Kohno Y
Allergol Int; 2012 Sep; 61(3):497-9. PubMed ID: 22722810
[No Abstract] [Full Text] [Related]
8. Central and extrapontine myelinolysis following allogeneic peripheral haematopoietic progenitor cell transplantation. Favourable outcome in a patient with chronic myeloid leukaemia.
Boqué C; Petit J; Aguilera C; Vicente L; Grañena A
Bone Marrow Transplant; 2003 Jan; 31(1):61-4. PubMed ID: 12621509
[TBL] [Abstract][Full Text] [Related]
9. Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation.
Nieto Y; Russ P; Everson G; Bearman SI; Cagnoni PJ; Jones RB; Shpall EJ
Bone Marrow Transplant; 2000 Jul; 26(1):109-11. PubMed ID: 10918414
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A-associated status epilepticus related to hematopoietic stem cell transplantation for thalassemia.
Zakrzewski JL
Pediatr Hematol Oncol; 2003 Sep; 20(6):481-6. PubMed ID: 14631624
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
Yu LX; Shan HT; Fu SJ; Du CF; Ma JJ; Xu J; Deng WF; Wang YB
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
[TBL] [Abstract][Full Text] [Related]
13. Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
Yamada MF; Miyamura K; Fujiwara T; Kohata K; Okitsu Y; Ohguchi H; Yamamoto J; Yokoyama H; Tomiya Y; Ishizawa K; Kameoka J; Harigae H
Transplant Proc; 2008 Dec; 40(10):3637-42. PubMed ID: 19100456
[TBL] [Abstract][Full Text] [Related]
14. Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation.
Steg RE; Kessinger A; Wszolek ZK
Bone Marrow Transplant; 1999 May; 23(9):959-62. PubMed ID: 10338054
[TBL] [Abstract][Full Text] [Related]
15. [Myelodysplastic syndrome with cyclosporine A-induced encephalopathy presenting with a mass effect on the right basal ganglia after cord blood transplantation].
Koh H; Yamane T; Nakane T; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Nakamae H; Koh KR; Mochizuki K; Hayashi N; Hino M
Rinsho Ketsueki; 2006 Dec; 47(12):1539-43. PubMed ID: 17233473
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation.
Nouri-Majelan N; Sanadgol H; Ghafari A; Rahimian M; Najafi F; Mortazavizadeh M; Moghaddasi S
Transplant Proc; 2005 Sep; 37(7):3213-5. PubMed ID: 16213351
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S
Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids.
Ogawa Y; Okamoto S; Kuwana M; Mori T; Watanabe R; Nakajima T; Yamada M; Mashima Y; Tsubota K; Oguchi Y
Cornea; 2001 May; 20(4):430-4. PubMed ID: 11333336
[TBL] [Abstract][Full Text] [Related]
20. [Asymmetric peripheral neuropathy following reduced-intensity cord blood transplantation].
Sumi M; Ichikawa N; Sato S; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
Rinsho Ketsueki; 2008 Dec; 49(12):1604-8. PubMed ID: 19110521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
